Displaying 1 - 50 of 124 results
Released Company Title Industry Topic
04 Jun 2024
08:00 CEST
PHOTOCURE Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S. 20103015 Pharmaceuticals Non-regulatory press releases
23 May 2024
19:33 CEST
PHOTOCURE Photocure ASA - Annual general meeting held 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
15 May 2024
08:00 CEST
PHOTOCURE Photocure ASA: Results for the first quarter of 2024 20103015 Pharmaceuticals Half yearly financial reports and audit reports/limited reviews
12 May 2024
10:24 CEST
PHOTOCURE Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China 20103015 Pharmaceuticals Non-regulatory press releases
08 May 2024
22:36 CEST
PHOTOCURE Photocure ASA: Invitation to presentation of first quarter 2024 financial results 20103015 Pharmaceuticals Non-regulatory press releases
07 May 2024
08:00 CEST
PHOTOCURE Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024 20103015 Pharmaceuticals Non-regulatory press releases
30 Apr 2024
13:49 CEST
PHOTOCURE Photocure ASA - Notice of the Annual General Meeting 23 May 2024 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
30 Apr 2024
11:52 CEST
PHOTOCURE Photocure ASA: Annual Report 2023 20103015 Pharmaceuticals Annual financial and audit Reports
30 Apr 2024
07:30 CEST
PHOTOCURE Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy 20103015 Pharmaceuticals Non-regulatory press releases
25 Apr 2024
21:53 CEST
PHOTOCURE Photocure ASA - Share option grant 20103015 Pharmaceuticals Mandatory notification of trade primary insiders
08 Apr 2024
12:33 CEST
PHOTOCURE European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care 20103015 Pharmaceuticals Non-regulatory press releases
05 Apr 2024
07:30 CEST
PHOTOCURE Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference 20103015 Pharmaceuticals Non-regulatory press releases
28 Mar 2024
13:14 CET
PHOTOCURE New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy 20103015 Pharmaceuticals Non-regulatory press releases
18 Mar 2024
10:05 CET
PHOTOCURE Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting 20103015 Pharmaceuticals Non-regulatory press releases
23 Feb 2024
08:35 CET
PHOTOCURE Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO 20103015 Pharmaceuticals Non-regulatory press releases
22 Feb 2024
08:37 CET
PHOTOCURE Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN 20103015 Pharmaceuticals Non-regulatory press releases
21 Feb 2024
08:00 CET
PHOTOCURE Photocure ASA: Results for the fourth quarter of 2023 20103015 Pharmaceuticals Half yearly financial reports and audit reports/limited reviews
19 Feb 2024
09:29 CET
PHOTOCURE Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2023 financial results 20103015 Pharmaceuticals Non-regulatory press releases
29 Jan 2024
08:47 CET
PHOTOCURE Photocure Partner Asieris presented clinical trial and real-world data on Hexvix in China at ASCO GU 2024 20103015 Pharmaceuticals Non-regulatory press releases
05 Jan 2024
08:51 CET
PHOTOCURE Financial calendar 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
21 Dec 2023
08:00 CET
PHOTOCURE Photocure ASA - Share option grant 20103015 Pharmaceuticals Mandatory notification of trade primary insiders
11 Dec 2023
08:09 CET
PHOTOCURE Photocure ASA – Major shareholding disclosure 20103015 Pharmaceuticals Major shareholding notifications
01 Dec 2023
07:30 CET
PHOTOCURE SUO 2023 Meeting: New Real World Evidence shows Significant Decrease in Risk of Bladder Cancer Recurrence with Blue Light Cystoscopy 20103015 Pharmaceuticals Non-regulatory press releases
29 Nov 2023
10:06 CET
PHOTOCURE Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China 20103015 Pharmaceuticals Non-regulatory press releases
20 Nov 2023
17:50 CET
PHOTOCURE Photocure to present at four investor conferences in November/December 2023 20103015 Pharmaceuticals Non-regulatory press releases
08 Nov 2023
08:00 CET
PHOTOCURE Photocure ASA: Results for the third quarter of 2023 20103015 Pharmaceuticals Half yearly financial reports and audit reports/limited reviews
01 Nov 2023
08:22 CET
PHOTOCURE Photocure ASA: Invitation to presentation of third quarter 2023 financial results 20103015 Pharmaceuticals Non-regulatory press releases
12 Oct 2023
10:32 CEST
PHOTOCURE Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress 20103015 Pharmaceuticals Non-regulatory press releases
08 Oct 2023
15:44 CEST
PHOTOCURE Photocure Partner Asieris to present first results for its Hexvix Phase III clinical trial in China at the SIU 2023 Annual Meeting 20103015 Pharmaceuticals Non-regulatory press releases
06 Oct 2023
15:07 CEST
PHOTOCURE New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines 20103015 Pharmaceuticals Non-regulatory press releases
02 Oct 2023
13:29 CEST
PHOTOCURE Major shareholder disclosure in Photocure ASA 20103015 Pharmaceuticals Major shareholding notifications
27 Sep 2023
18:06 CEST
PHOTOCURE Photocure ASA: Change of Board Composition 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
25 Sep 2023
13:59 CEST
PHOTOCURE Major shareholder disclosure in Photocure ASA 20103015 Pharmaceuticals Major shareholding notifications
20 Sep 2023
12:17 CEST
PHOTOCURE Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint 20103015 Pharmaceuticals Non-regulatory press releases
30 Aug 2023
16:06 CEST
PHOTOCURE Photocure ASA: Notification of primary insider transaction 20103015 Pharmaceuticals Mandatory notification of trade primary insiders
11 Aug 2023
11:05 CEST
PHOTOCURE Photocure Partner Asieris confirms Hexvix Phase III clinical trial in China meets endpoint 20103015 Pharmaceuticals Non-regulatory press releases
09 Aug 2023
08:00 CEST
PHOTOCURE Photocure ASA: Results for the second quarter and first half of 2023 20103015 Pharmaceuticals Half yearly financial reports and audit reports/limited reviews
08 Aug 2023
14:26 CEST
PHOTOCURE Major shareholder disclosure in Photocure ASA 20103015 Pharmaceuticals Major shareholding notifications
03 Aug 2023
08:13 CEST
PHOTOCURE Photocure ASA: Invitation to presentation of second quarter and first half year 2023 financial results 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
06 Jul 2023
10:40 CEST
PHOTOCURE Photocure Partner Asieris announces completion of enrollment for Hexvix Phase III clinical trial in China 20103015 Pharmaceuticals Non-regulatory press releases
01 Jun 2023
14:36 CEST
PHOTOCURE Major shareholder disclosure 20103015 Pharmaceuticals Major shareholding notifications
24 May 2023
08:32 CEST
PHOTOCURE Photocure ASA - Share option grant 20103015 Pharmaceuticals Mandatory notification of trade primary insiders
10 May 2023
08:00 CEST
PHOTOCURE Photocure ASA: Results for the first quarter of 2023 20103015 Pharmaceuticals Half yearly financial reports and audit reports/limited reviews
04 May 2023
13:22 CEST
PHOTOCURE Photocure ASA - Correction: Annual general meeting held 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
03 May 2023
18:41 CEST
PHOTOCURE Photocure ASA - Annual general meeting held 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
03 May 2023
11:38 CEST
PHOTOCURE Photocure ASA: Invitation to presentation of first quarter 2023 financial results 20103015 Pharmaceuticals Non-regulatory press releases
12 Apr 2023
16:01 CEST
PHOTOCURE Photocure ASA: Annual Report 2022 20103015 Pharmaceuticals Annual financial and audit Reports
12 Apr 2023
16:01 CEST
PHOTOCURE Photocure ASA - Notice of the Annual General Meeting 3 May 2023 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
11 Apr 2023
08:09 CEST
PHOTOCURE Major shareholder disclosure - Photocure ASA 20103015 Pharmaceuticals Major shareholding notifications
04 Apr 2023
13:55 CEST
PHOTOCURE Major shareholder disclosure in Photocure ASA 20103015 Pharmaceuticals Major shareholding notifications